BioNTech

BioNTech Clears Major Acquisition Milestone Amid Sector Headwinds

December 6, 2025

BioNTech Clears Final Hurdle in CureVac Acquisition

kashif hafeez - December 5, 2025

BioNTech Consolidates mRNA Leadership with CureVac Acquisition Finalized

angelina - December 4, 2025

Regulatory Headwinds Rattle BioNTech and Vaccine Sector

Brett Shapiro - December 2, 2025

BioNTech Shares Plunge Amid Regulatory Concerns

angelina - December 1, 2025

BioNTech Clears Major Hurdle in Strategic Acquisition

November 27, 2025

BioNTech Shares Face Critical Test Amid Strategic Shifts

angelina - November 26, 2025

BioNTech’s Strategic Acquisition Reaches Critical Shareholder Vote

Brett Shapiro - November 25, 2025

BioNTech Investors Await Crucial Acquisition Verdict

angelina - November 24, 2025

BioNTech Faces Pivotal Moment as Pfizer Cuts Stake

angelina - November 18, 2025

BioNTech’s Strategic Crossroads: High-Stakes Acquisition and Partnership Shifts

angelina - November 18, 2025

Pfizer Divests Majority Stake in BioNTech, Signaling Strategic Shift

kashif hafeez - November 15, 2025

BioNTech Shares Face Pressure as Pfizer Exits Stake

angelina - November 15, 2025

Pfizer’s Strategic Shift Sends Ripples Through BioNTech Investment

Brett Shapiro - November 13, 2025

BioNTech Shares: A Potential Turning Point?

kashif hafeez - November 11, 2025

1 234 Page 3 of 4